GET THE APP

Angiology: Open Access

Angiology: Open Access
Open Access

ISSN: 2329-9495

+44 1478 350008

Perspective - (2023)

Complications of Hyperlipidemia Related to Heart

Hong Hee Won*
 
*Correspondence: Hong Hee Won, Department of Medicine, Sungkyunkwan University, Seoul, Republic of Korea, Email:

Author info »

Description

Hyperlipidemia is a condition in which there are high levels of lipids (fats) in the blood. These lipids include cholesterol and triglycerides, and when they are present in excessive amounts, they can leads to the development of heart disease.

Causes

Hyperlipidemia can be caused by a variety of factors, including genetics, diet, and lifestyle. Some people are genetically predisposed to hyperlipidemia that means their bodies naturally produce more amounts of cholesterol and triglycerides than normal. In these cases, a healthy diet and exercise may not be enough to control cholesterol and triglyceride levels.

Diet is another major factor in the development of hyperlipidemia. Consuming a diet high in saturated and trans fats, as well as processed foods, can lead to elevated cholesterol and triglyceride levels. On the other hand, a diet rich in fruits, vegetables, whole grains, and lean proteins can help to reduce cholesterol and triglycerides.

Lifestyle factors, such as lack of exercise and smoking, can also contribute to the development of hyperlipidemia. Regular physical activity and quitting smoking can help to improve cholesterol and triglyceride levels.

Symptoms

Hyperlipidemia itself does not typically cause any symptoms. In fact, many people with high cholesterol and triglyceride levels may not even know that they have the condition. However, over time, elevated lipid levels can contribute to the development of heart disease and its associated symptoms.

Symptoms of heart disease may include chest pain or discomfort, shortness of breath, fatigue, and irregular heartbeat. In some cases, heart disease can also lead to more serious complications, such as heart attack or stroke.

Diagnosis

Hyperlipidemia is typically diagnosed through a blood test that measures cholesterol and triglyceride levels. This test is called a lipid panel or lipid profile. The test may be ordered by a healthcare provider as part of a routine checkup or if there is a family history of hyperlipidemia or heart disease.

The lipid panel will measure several different components of the blood, including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. These values will be compared to established guidelines to determine if they are within a healthy range.

Treatment

The treatment of hyperlipidemia depends on the severity of the condition and the individual's overall health status. In many cases, lifestyle changes, such as dietary modifications and increased exercise, can be enough to bring cholesterol and triglyceride levels back into a healthy range.

Prevention

Prevention is the best way to manage hyperlipidemia and reduce the risk of heart disease. Some key strategies for preventing hyperlipidemia include, eating a healthy diet that is low in saturated and trans fats, and rich in fruits, vegetables, whole grains, and lean proteins. Doing a regular physical activities like walking, jogging, or cycling, for at least 30 minutes per day and maintaining a healthy weight.

Conclusion

For people with more severe hyperlipidemia, medications may be necessary to control cholesterol and triglyceride levels. The most commonly prescribed medications for hyperlipidemia are statins, which work by reducing the production of cholesterol in the liver. Other medications, such as bile acid sequestrants, niacin, and fibric acid derivatives, may also be used to treat hyperlipidemia. These medications work in different ways to control lipid levels in the blood.

Author Info

Hong Hee Won*
 
Department of Medicine, Sungkyunkwan University, Seoul, Republic of Korea
 

Citation: Won HH (2023) Complications of Hyperlipidemia Related to Heart. Angiol Open Access. S1:002.

Received: 01-Mar-2023, Manuscript No. AOA-23-23077; Editor assigned: 03-Mar-2023, Pre QC No. AOA-23-23077 (PQ); Reviewed: 17-Mar-2023, QC No. AOA-23-23077; Revised: 24-Mar-2023, Manuscript No. AOA-23-23077 (R); Published: 31-Mar-2023 , DOI: 10.35248/2329-9495.23.S1.002

Copyright: © 2023 Won HH. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top